Best Practices for Managing FDA Investigators and Handling FDA 483 Observations
September 30, 2010(Ended)
Online Webinar
This course offers a unique perspective and is a succinct overview of best practices that can really help you avoid these compliance situations, described aboveAreas Covered in the Seminar:
- Inspectional preparations and logistics.
- Manage the FDA Investigator for the best outcome.
- Influence FDA decision-makers.
- Properly accept FDA 483.
- Respond strategically to FDA 483.
- Develop a strategic Corrective Action Plan.
- Intercept and Avoid a Warning Letter.
Who Will Benefit:
- Executive Managers faced with a future FDA inspection
- Personnel with direct and indirect FDA contact prior, during, and after a FDA inspection
- Quality Assurance managers and personnel
- Regulatory Affairs and Compliance managers and personnel
Prices *
199-199 US Dollar
Exhibition
No exhibition
Organization
Categories
Concurrent events
- Development, Management, and Operation of an Effective Supplier and Internal Auditing System - Webinar by GlobalCompliancePanel 2010
- Managing Product Medical Device Recall Efficiently and Effectively - Webinar by GlobalCompliancePanel 2010
- How to Survive a DEA Audit or FIND=FINE - Webinar by GlobalCompliancePanel 2010
- Project Management Certification Study Group - Information Year 2010
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- An Industrial conference as a vital tool to promote an industry
- Business conference and trade shows as an efficient tool
- Business Seminars can Change your Outlook
- Determine the prevalence of hypermetropia among young male and female
- Cancer Basic Research
- Corneal endothelial recovery in patients undergoing small incision cataract surgery comparison between diabetics and non diabetics.
